GOID	Ontology Source	GOTerm	GOLevels	GOGroups	Nr. Genes	% Associated Genes	Term PValue	Term PValue Corrected with Bonferroni step down	Group PValue	Group PValue Corrected with Bonferroni step down	Associated Genes Found	All Associated Genes	OverViewTerm
WP:45	WikiPathways_09.11.2015	G1 to S cell cycle control	[-1]	[Group11, Group2]	4	5.882353	0.007991586951647615	0.2157728476944856	{Group11=1.2070874642210286E-5, Group2=2.9863853183912796E-5}	{Group11=1.4485049570652343E-4, Group2=3.2850238502304073E-4}	[CDC25A, CREB1, PCNA, WEE1]	[ATF6B, ATM, CCNA1, CCNB1, CCND1, CCND2, CCND3, CCNE1, CCNE2, CCNG2, CCNH, CDC25A, CDC45, CDK1, CDK2, CDK4, CDK6, CDK7, CDKN1A, CDKN1B, CDKN1C, CDKN2A, CDKN2B, CDKN2C, CDKN2D, CREB1, CREB3, CREB3L1, CREB3L3, CREB3L4, E2F1, E2F2, E2F3, E2F4, E2F5, E2F6, GADD45A, MCM2, MCM3, MCM4, MCM5, MCM6, MCM7, MDM2, MNAT1, MYC, MYT1, ORC1, ORC2, ORC3, ORC4, ORC5, ORC6, PCNA, POLA2, POLE, POLE2, PRIM1, PRIM2, RB1, RBL1, RPA1, RPA2, RPA3, TFDP1, TFDP2, TP53, WEE1]	FALSE
WP:179	WikiPathways_09.11.2015	Cell Cycle	[-1]	[Group11]	5	4.854369	0.0068397490726727975	0.19151297403483833	{Group11=1.2070874642210286E-5}	{Group11=1.4485049570652343E-4}	[ATR, CDC25A, PCNA, PRKDC, WEE1]	[ABL1, APC, ARF1, ATM, ATR, BUB1, BUB1B, BUB3, CCNA1, CCNA2, CCNB1, CCNB2, CCNB3, CCND2, CCND3, CCNE1, CCNE2, CCNH, CDC14A, CDC14B, CDC20, CDC25A, CDC25B, CDC25C, CDC45, CDC6, CDC7, CDH1, CDK1, CDK2, CDK4, CDK6, CDKN1A, CDKN1B, CDKN2A, CHEK1, CHEK2, DBF4, E2F1, E2F2, E2F3, E2F4, E2F5, E2F6, EP300, ESPL1, GADD45A, GSK3B, HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, KITLG, MAD1L1, MAD2L1, MAD2L2, MCM10, MCM2, MCM3, MCM4, MCM5, MCM6, MCM7, MCM8, MCM9, MDM2, MEN1, MPEG1, ORC1, ORC2, ORC3, ORC4, ORC5, ORC6, PCNA, PKMYT1, PLK1, PRKDC, PTTG1, PTTG2, PTTG3P, RB1, RBL1, SKP2, SMAD3, SMAD4, SMC1A, TBC1D8, TFDP1, TGFB1, TP53, UBE2F, WEE1, YWHAB, YWHAE, YWHAG, YWHAH, YWHAQ, YWHAZ]	FALSE
WP:186	WikiPathways_09.11.2015	Homologous recombination	[-1]	[Group8]	2	15.384615	0.009741845465669018	0.25328798210739445	{Group8=0.009751989143345501}	{Group8=0.0682639240034185}	[BRCA2, POLD1]	[ATM, BRCA2, MRE11A, NBN, POLD1, POLD2, POLD3, POLD4, RAD50, RAD51, RAD52, RAD54B, RPA1]	FALSE
WP:229	WikiPathways_09.11.2015	Irinotecan Pathway	[-1]	[Group3]	1	7.142857	0.15272853922144577	1.0	{Group3=0.15272853922144577}	{Group3=0.6109141568857831}	[ABCC1]	[ABCC1, ABCC2, ABCG2, APC, BCHE, CES1, CES2, CYP3A4, CYP3A5, NPC1, SLCO1B1, UGT1A1, UGT1A10, UGT1A9]	TRUE
WP:231	WikiPathways_09.11.2015	TNF alpha Signaling Pathway	[-1]	[Group2]	4	4.347826	0.022288569017630936	0.5126370874055115	{Group2=2.9863853183912796E-5}	{Group2=3.2850238502304073E-4}	[BIRC2, MAP3K1, NFKB2, SKP1]	[AKT1, APAF1, BAD, BAX, BCL2L1, BID, BIRC2, BIRC3, BTRC, CASP3, CASP7, CASP8, CASP9, CCL2, CDC37, CFLAR, CHUK, CREBBP, CSNK2A1, CUL1, CYBA, DIABLO, FADD, FBXW11, GLUL, GRB2, HRAS, HSP90AA1, IKBKB, IKBKG, IL6, JUN, KRAS, KSR1, KSR2, MADD, MAP2K3, MAP2K4, MAP2K6, MAP2K7, MAP3K1, MAP3K14, MAP3K3, MAP3K5, MAP3K7, MAP3K8, MAP4K2, MAPK1, MAPK3, MAPK8, MAPK9, NFKB1, NFKB2, NFKBIA, NFKBIB, NFKBIE, NOX1, NOXO1, NRAS, NSMAF, OTUD7B, PLK1, PPP2CA, PRKCZ, PSMD2, PTPRCAP, PYGL, RAC1, RAF1, REL, RFFL, RFK, RIPK1, RIPK3, SELE, SKP1, SMPD2, SOS1, TAB1, TAB2, TAB3, TANK, TBK1, TNF, TNFAIP3, TNFRSF1A, TNFRSF1B, TRADD, TRAF1, TRAF2, TRAP1, TXN]	FALSE
WP:254	WikiPathways_09.11.2015	Apoptosis	[-1]	[Group2]	5	5.952381	0.002856251696782413	0.08854380260025481	{Group2=2.9863853183912796E-5}	{Group2=3.2850238502304073E-4}	[BIRC2, BIRC5, IGF1, MAP3K1, SCAF11]	[AKT1, APAF1, BAD, BAK1, BAX, BBC3, BCL2, BCL2L1, BCL2L11, BCL2L2, BID, BIRC2, BIRC3, BIRC5, BNIP3L, BOK, CASP1, CASP10, CASP2, CASP3, CASP4, CASP6, CASP7, CASP8, CASP9, CDKN2A, CFLAR, CHUK, CRADD, CYCS, DFFA, DFFB, DIABLO, FADD, FAS, FASLG, GZMB, HELLS, HRK, IGF1, IGF1R, IGF2, IKBKB, IKBKG, IRF1, IRF2, IRF3, IRF4, IRF5, IRF6, IRF7, JUN, LTA, MAP2K4, MAP3K1, MAPK10, MCL1, MDM2, MYC, NFKB1, NFKBIA, NFKBIB, NFKBIE, PIK3R1, PMAIP1, PRF1, RELA, RIPK1, SCAF11, TNF, TNFRSF10B, TNFRSF1A, TNFRSF1B, TNFRSF21, TNFRSF25, TNFSF10, TP53, TP63, TP73, TRADD, TRAF1, TRAF2, TRAF3, XIAP]	FALSE
WP:262	WikiPathways_09.11.2015	EBV LMP1 signaling	[-1]	[Group2]	1	5.0	0.21093836321090575	0.843753452843623	{Group2=2.9863853183912796E-5}	{Group2=3.2850238502304073E-4}	[NFKB2]	[CCL20, CHUK, CXCL8, HSP90AA1, IFNB1, IKBKB, IRAK1, MAP3K14, MAP3K3, MAP3K7, MAPK1, MAPK8, NFKB1, NFKB2, NFKBIA, PDLIM7, RELA, TRADD, TRAF1, TRAF6]	FALSE
WP:314	WikiPathways_09.11.2015	FAS pathway and Stress induction of HSP regulation	[-1]	[Group2, Group7]	2	4.7619047	0.08667909303650473	1.0	{Group2=2.9863853183912796E-5, Group7=0.0055153943105859015}	{Group2=3.2850238502304073E-4, Group7=0.049638548795273116}	[MAP3K1, PRKDC]	[ACTA1, ACTB, ACTG1, APAF1, ARHGDIB, BCL2, CASP10, CASP3, CASP6, CASP7, CASP8, CASP9, CFLAR, CYCS, DAXX, DFFA, DFFB, FADD, FAF1, FAS, FASLG, HSPB1, IL1A, JUN, LMNA, LMNB1, LMNB2, MAP2K4, MAP3K1, MAP3K7, MAPK8, MAPKAPK2, MAPKAPK3, NFX1, PAK1, PAK2, PARP1, PRKDC, RB1, RIPK2, SPTAN1, TNF]	FALSE
WP:384	WikiPathways_09.11.2015	Apoptosis Modulation by HSP70	[-1]	[Group2, Group7]	1	5.263158	0.20151722510892747	1.0	{Group2=2.9863853183912796E-5, Group7=0.0055153943105859015}	{Group2=3.2850238502304073E-4, Group7=0.049638548795273116}	[MAP3K1]	[AIFM1, APAF1, BID, CASP2, CASP3, CASP6, CASP7, CASP8, CASP9, CYCS, FADD, FAS, FASLG, HSPA1A, MAP3K1, MAPK10, NFKB1, RIPK1, TNFRSF1A]	FALSE
WP:391	WikiPathways_09.11.2015	Mitochondrial Gene Expression	[-1]	[Group2]	2	10.0	0.02251560118105851	0.4953432259832873	{Group2=2.9863853183912796E-5}	{Group2=3.2850238502304073E-4}	[CREB1, HCFC1]	[CAMK4, CREB1, ESRRA, FLJ10038, GABPA, GABPB1, HCFC1, MTERF1, MTERF3, MYEF2, NRF1, POLRMT, PPARGC1A, PPARGC1B, PPP3CA, PPRC1, SP1, TFAM, TFB1M, TFB2M]	FALSE
WP:400	WikiPathways_09.11.2015	p38 MAPK Signaling Pathway	[-1]	[Group2, Group7]	2	5.882353	0.05990558759334167	1.0	{Group2=2.9863853183912796E-5, Group7=0.0055153943105859015}	{Group2=3.2850238502304073E-4, Group7=0.049638548795273116}	[CREB1, MAP3K1]	[ATF2, CDC42, CREB1, DAXX, DDIT3, ELK1, GRB2, HMGN1, HRAS, HSPB1, MAP2K4, MAP2K6, MAP3K1, MAP3K5, MAP3K7, MAP3K9, MAPK14, MAPKAPK2, MAPKAPK5, MAX, MEF2D, MKNK1, MYC, PLA2G4A, RAC1, RASGRF1, RIPK1, RPS6KA5, SHC1, STAT1, TGFB2, TGFBR1, TRADD, TRAF2]	FALSE
WP:404	WikiPathways_09.11.2015	Nucleotide Metabolism	[-1]	[Group8]	2	10.526316	0.02041631512027884	0.48999156288669216	{Group8=0.009751989143345501}	{Group8=0.0682639240034185}	[POLD1, RRM2]	[ADSL, ADSS, DHFR, HPRT1, IMPDH1, MTHFD2, NME2, OAZ1, POLA1, POLB, POLD1, POLG, PRPS1, PRPS2, RRM1, RRM2, RRM2B, SAT1, SRM]	FALSE
WP:422	WikiPathways_09.11.2015	MAPK Cascade	[-1]	[Group2, Group7]	2	6.8965516	0.04499033432385519	0.8548163521532487	{Group2=2.9863853183912796E-5, Group7=0.0055153943105859015}	{Group2=3.2850238502304073E-4, Group7=0.049638548795273116}	[MAP2, MAP3K1]	[ARAF, BRAF, ELK1, HRAS, JUN, KRAS, MAP2, MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K6, MAP2K7, MAP3K1, MAP3K12, MAP3K2, MAP3K3, MAPK1, MAPK10, MAPK12, MAPK14, MAPK3, MBP, NRAS, PLCB3, RAF1, RASA3, RRAS, SIPA1]	FALSE
WP:438	WikiPathways_09.11.2015	Non-homologous end joining	[-1]	[Group7]	2	28.571428	0.002744283195167378	0.0878170622453561	{Group7=0.0055153943105859015}	{Group7=0.049638548795273116}	[PRKDC, XRCC6]	[MRE11A, NHEJ1, PRKDC, RAD50, XRCC4, XRCC5, XRCC6]	TRUE
WP:466	WikiPathways_09.11.2015	DNA Replication	[-1]	[Group8]	2	4.7619047	0.08667909303650473	1.0	{Group8=0.009751989143345501}	{Group8=0.0682639240034185}	[PCNA, POLD1]	[CDC45, CDC6, CDC7, CDK2, CDT1, DBF4, GMNN, MCM10, MCM2, MCM3, MCM4, MCM5, MCM6, MCM7, ORC1, ORC2, ORC3, ORC4, ORC5, ORC6, PCNA, POLA1, POLA2, POLD1, POLD2, POLD3, POLD4, POLE, POLE2, PRIM1, PRIM2, RFC1, RFC2, RFC3, RFC4, RFC5, RPA1, RPA2, RPA3, RPA4, UBA52, UBC]	FALSE
WP:531	WikiPathways_09.11.2015	Mismatch repair	[-1]	[Group8]	2	22.222221	0.004633904133141132	0.13901712399423397	{Group8=0.009751989143345501}	{Group8=0.0682639240034185}	[PCNA, POLD1]	[EXO1, LIG1, MLH1, MSH2, MSH6, PCNA, POLD1, RFC1, RPA1]	TRUE
WP:585	WikiPathways_09.11.2015	Interferon type I signaling pathways	[-1]	[Group2, Group7]	3	5.5555553	0.025009690433550197	0.5252034991045541	{Group2=2.9863853183912796E-5, Group7=0.0055153943105859015}	{Group2=3.2850238502304073E-4, Group7=0.049638548795273116}	[CREB1, MAP3K1, MTOR]	[CBL, CREB1, CRK, CRKL, EIF4A1, EIF4B, EIF4E, EIF4EBP1, FYN, GAB2, GNB2L1, IFNAR1, IFNAR2, IRF9, IRS1, IRS2, JAK1, LCK, MAP2K3, MAP2K6, MAP3K1, MAPK14, MAPKAP1, MLST8, MTOR, PDCD4, PIAS1, PIAS3, PIK3CD, PIK3R1, PIK3R2, PRMT1, PTPN11, PTPN6, PTPRC, RAC1, RAP1A, RAPGEF1, REL, RPS6, RPS6KA4, RPS6KA5, RPS6KB1, RPTOR, SOCS1, SOCS3, STAT1, STAT2, STAT3, STAT4, STAT5A, TYK2, VAV1, ZAP70]	FALSE
WP:615	WikiPathways_09.11.2015	Senescence and Autophagy in Cancer	[-1]	[Group9]	6	5.714286	0.001322335778229759	0.04363708068158205	{Group9=0.001322335778229759}	{Group9=0.013223357782297591}	[ATG10, ATG5, ATG7, IGF1, MTOR, PCNA]	[AKT1S1, AMBRA1, ATG10, ATG12, ATG13, ATG14, ATG16L1, ATG3, ATG5, ATG7, BCL2, BECN1, BMI1, BMP2, BRAF, CCL3, CD44, CDC25B, CDKN1A, CDKN1B, CDKN2A, CEBPB, COL10A1, COL1A1, COL3A1, CREG1, CXCL1, CXCL14, CXCL8, E2F1, FKBP8, FN1, GABARAP, GABARAPL1, GABARAPL2, GSK3B, GSN, HMGA1, HRAS, IFI16, IFNB1, IFNG, IGF1, IGF1R, IGFBP3, IGFBP5, IGFBP7, IL1A, IL1B, IL24, IL3, IL6, IL6R, IL6ST, ING1, ING2, INHBA, INS, IRF1, IRF5, IRF7, JUN, KMT2A, LAMP1, LAMP2, MAP1LC3A, MAP1LC3B, MAP1LC3C, MAP2K1, MAP2K3, MAPK1, MAPK14, MDM2, MLST8, MMP14, MTOR, PCNA, PIK3C3, PLAT, PLAU, PTEN, RAF1, RB1, RB1CC1, RNASEL, RSL1D1, SERPINB2, SERPINE1, SH3GLB1, SLC39A1, SLC39A2, SLC39A3, SLC39A4, SMAD3, SMAD4, SPARC, SQSTM1, SRC, TGFB1, THBS1, TNFSF15, TP53, ULK1, UVRAG, VTN]	TRUE
WP:707	WikiPathways_09.11.2015	DNA Damage Response	[-1]	[Group11, Group2]	6	8.823529	1.256787198990302E-4	0.0045244339163650876	{Group11=1.2070874642210286E-5, Group2=2.9863853183912796E-5}	{Group11=1.4485049570652343E-4, Group2=3.2850238502304073E-4}	[ATR, BRCA1, CDC25A, CREB1, PRKDC, TLK1]	[ABL1, APAF1, ATM, ATR, ATRIP, BAX, BBC3, BID, BRCA1, CASP3, CASP8, CASP9, CCNB1, CCNB2, CCNB3, CCND1, CCND2, CCND3, CCNE1, CCNE2, CDC25A, CDC25C, CDK1, CDK2, CDK4, CDK5, CDK6, CDKN1A, CDKN1B, CHEK1, CHEK2, CREB1, CYCS, DDB2, E2F1, FANCD2, FAS, GADD45A, GADD45B, GADD45G, H2AFX, HUS1B, MDM2, MRE11A, MYC, NBN, PIDD1, PMAIP1, PML, PRKDC, RAD1, RAD17, RAD50, RAD51, RAD52, RAD9A, RB1, RFC1, RPA2, RRM2B, SESN1, SFN, SMC1A, TLK1, TLK2, TNFRSF10B, TP53, TP53AIP1]	TRUE
WP:712	WikiPathways_09.11.2015	Estrogen signaling pathway	[-1]	[Group2]	1	4.347826	0.2385513564204811	0.4771027128409622	{Group2=2.9863853183912796E-5}	{Group2=3.2850238502304073E-4}	[CREB1]	[AKT1, BCL2, BRAF, CHUK, CREB1, ELK1, ESR1, FOS, GNAS, GNB1, GNGT1, GPER1, IKBKB, IKBKG, JUN, MAP2K1, MAPK1, MAPK14, MAPK9, NFKB1, PIK3CA, PRKACA, SP1]	FALSE
WP:734	WikiPathways_09.11.2015	Serotonin Receptor 4/6/7 and NR3C Signaling	[-1]	[Group2]	1	5.263158	0.20151722510892747	1.0	{Group2=2.9863853183912796E-5}	{Group2=3.2850238502304073E-4}	[CREB1]	[ATF1, BRAF, CREB1, EGR1, ELK1, ELK4, GNAS, HTR4, HTR6, HTR7, MAP2K1, MAP2K2, MAPK1, MAPK3, MAPKAPK2, NR3C1, RAP1A, RPS6KA5, SRF]	FALSE
WP:1422	WikiPathways_09.11.2015	Sphingolipid Metabolism	[-1]	[Group0]	1	5.0	0.21093836321090575	0.843753452843623	{Group0=0.21093836321090575}	{Group0=0.4218767264218115}	[SPTLC1]	[ASAH1, ASAH2, B4GALT6, CERK, CERS2, CERS3, CERS4, CERS5, CERS6, GAL3ST1, KDSR, PLPP1, SERINC1, SGMS2, SGPP2, SPHK1, SPHK2, SPTLC1, SPTLC2, SPTLC3]	TRUE
WP:1530	WikiPathways_09.11.2015	miRNA Regulation of DNA Damage Response	[-1]	[Group11, Group2]	6	6.976744	4.5870714231635107E-4	0.016054749981072286	{Group11=1.2070874642210286E-5, Group2=2.9863853183912796E-5}	{Group11=1.4485049570652343E-4, Group2=3.2850238502304073E-4}	[ATR, BRCA1, CDC25A, CREB1, PRKDC, TLK1]	[ABL1, APAF1, ATM, ATR, ATRIP, BAX, BBC3, BID, BRCA1, CASP3, CASP8, CASP9, CCNB1, CCNB2, CCNB3, CCND1, CCND2, CCND3, CCNE1, CCNE2, CCNG1, CDC20B, CDC25A, CDC25C, CDK1, CDK2, CDK4, CDK5, CDK6, CDKN1A, CDKN1B, CHEK1, CHEK2, CREB1, CYCS, DDB2, E2F1, FANCD2, FAS, GADD45A, GADD45B, GADD45G, H2AFX, HUS1B, MCM7, MDM2, MIR106B, MIR16-1, MIR17HG, MIR181A1, MIR203A, MIR21, MIR210, MIR221, MIR222, MIR223, MIR3074, MIR330, MIR373, MIR449A, MIR449B, MRE11A, MYC, NBN, PIDD1, PMAIP1, PML, PRKDC, RAD1, RAD17, RAD50, RAD51, RAD52, RAD9A, RB1, RFC1, RPA2, RRM2B, SESN1, SFN, SMC1A, TLK1, TLK2, TNFRSF10B, TP53, TP53AIP1]	FALSE
WP:1539	WikiPathways_09.11.2015	Angiogenesis	[-1]	[Group4]	1	4.1666665	0.24754298117348875	0.24754298117348875	{Group4=0.24754298117348875}	{Group4=0.24754298117348875}	[KDR]	[AKT1, ANGPT1, ARNT, CREBBP, FGF2, FGFR2, FLT1, HIF1A, KDR, MAPK1, MAPK14, MMP9, NOS3, PDGFB, PDGFRA, PIK3CA, PLCG1, PTK2, SMAD1, SRC, TEK, TIMP2, TIMP3, VEGFA]	TRUE
WP:1545	WikiPathways_09.11.2015	miRNAs involved in DNA damage response	[-1]	[Group11, Group2]	2	4.6511626	0.09024285018444492	1.0	{Group11=1.2070874642210286E-5, Group2=2.9863853183912796E-5}	{Group11=1.4485049570652343E-4, Group2=3.2850238502304073E-4}	[CDC25A, CREB1]	[ABL1, ATM, CCND1, CCND3, CCNE1, CDC25A, CDK6, CDKN1A, CDKN1B, CREB1, E2F1, H2AFX, MIR100, MIR106B, MIR143, MIR15B, MIR16-1, MIR181A1, MIR181B1, MIR203A, MIR21, MIR210, MIR221, MIR222, MIR223, MIR23A, MIR23B, MIR25, MIR27A, MIR3074, MIR330, MIR371A, MIR372, MIR373, MIR449A, MIR449B, MIR449C, MIR503, MIR93, MIRLET7B, MYC, RAD52, TP53]	FALSE
WP:1584	WikiPathways_09.11.2015	Type II diabetes mellitus	[-1]	[Group2]	1	4.5454545	0.22945419173789686	0.6883625752136906	{Group2=2.9863853183912796E-5}	{Group2=3.2850238502304073E-4}	[MTOR]	[ADIPOQ, CACNA1A, GK, IKBKB, INS-IGF2, INSR, IRS1, KCNJ11, MAFA, MAPK1, MAPK8, MTOR, PDX1, PHKA2, PIK3R5, PRKCD, PRKCZ, SLC2A2, SLC2A4, SOCS4, SURF1, TNF]	FALSE
WP:1589	WikiPathways_09.11.2015	Folate-Alcohol and Cancer Pathway	[-1]	[Group2]	1	11.111111	0.10101419993906365	1.0	{Group2=2.9863853183912796E-5}	{Group2=3.2850238502304073E-4}	[CREB1]	[ADH5, ALDH1A1, ALDH1L1, CBS, CBSL, CEBPB, CREB1, CYP2E1, MTHFR]	FALSE
WP:1601	WikiPathways_09.11.2015	Fluoropyrimidine Activity	[-1]	[Group10]	3	9.090909	0.006541466871618951	0.18970253927694958	{Group10=0.006541466871618951}	{Group10=0.052331734972951606}	[RRM2, SMUG1, TYMS]	[ABCC3, ABCC4, ABCC5, ABCG2, CDA, CES1, CES2, CYP2A6, DHFR, DPYD, DPYS, ERCC2, FPGS, GGH, MTHFR, PPAT, RRM1, RRM2, SLC22A7, SLC29A1, SMUG1, TDG, TK1, TP53, TYMP, TYMS, UCK1, UCK2, UMPS, UPB1, UPP1, UPP2, XRCC3]	TRUE
WP:1604	WikiPathways_09.11.2015	Codeine and Morphine Metabolism	[-1]	[Group1]	1	12.5	0.09030527818245868	1.0	{Group1=0.056714486052509484}	{Group1=0.3402869163150569}	[ABCB1]	[ABCB1, ABCC2, ABCC3, CYP2D6, CYP3A4, SLCO1B1, UGT1A1, UGT2B7]	FALSE
WP:1971	WikiPathways_09.11.2015	Integrated Cancer pathway	[-1]	[Group11]	3	6.521739	0.01634648586252899	0.40866214656322475	{Group11=1.2070874642210286E-5}	{Group11=1.4485049570652343E-4}	[ATR, BRCA1, CDC25A]	[AKT1, ATF1, ATM, ATR, BACH1, BAD, BARD1, BAX, BBC3, BCL2, BLM, BRCA1, CASP3, CASP8, CASP9, CDC25A, CDC25B, CDK1, CDK2, CDK4, CDKN1A, CDKN1B, CDKN2B, CHEK1, CHEK2, E2F1, GRIK1-AS2, JAK1, MAP3K5, MDM2, MIR21, MMP1, MRE11A, MSH2, MSH6, MYC, NOXA1, PLK1, POU2F1, PTEN, RAD50, RB1, SMAD2, SMAD3, STAT1, TP53]	FALSE
WP:1984	WikiPathways_09.11.2015	Integrated Breast Cancer Pathway	[-1]	[Group11]	9	5.9210525	5.7168382942543634E-5	0.002172398551816658	{Group11=1.2070874642210286E-5}	{Group11=1.4485049570652343E-4}	[ATR, AURKA, BRCA1, BRCA2, CDC25A, CREB1, FAU, MTOR, WEE1]	[ABL1, AHR, AKT1, ALKBH1, ANXA1, APOBEC3G, AR, ARAF, ATF1, ATM, ATR, AURKA, BACH1, BAD, BAK1, BARD1, BAX, BCL2, BID, BLM, BMPR1A, BMPR2, BRAF, BRCA1, BRCA2, CASP3, CASP8, CASP9, CCNB1IP1, CCND1, CDC25A, CDC25B, CDC42, CDH1, CDK2, CDK4, CDK7, CERK, CHEK1, CHEK2, CHUK, CREB1, CSNK1D, CTNNB1, CYP19A1, DAG1, DCAKD, DHTKD1, E2F1, EDAR, EGFR, EP300, ERAL1, ESR1, FADD, FAU, FER, FILIP1, FOSL1, FOXO1, GADD45A, GDI1, GRIK1-AS2, GRN, GSK3A, HDAC1, HIPK2, HMGCR, IMPA1, IRS1, ITPKC, JAK1, JAKMIP1, JUN, KRAS, LGALS13, MAP3K13, MAP3K7CL, MAPK1, MAX, MDM2, MIR21, MMP1, MRE11A, MSH2, MSH6, MTOR, MYC, MYCBP2, MYT1, NAB1, NCOA3, NF1, NFKB1, NOXA1, NUP85, ODC1, PAK1, PHB, PIAS1, PIGR, PIK3R2, PKIA, PLK1, PLK3, PML, PPP4R3A, PTEN, RAC1, RAD50, RAD51, RAD54L, RALA, RALGAPA1, RAP1A, RASGEF1A, RASGRP3, RB1, RHEB, RHO, RPP38, RRAS, SIRT1, SMAD1, SMAD2, SMAD4, SMAD6, SMAD7, SMARCA4, SP1, STAT1, STK11, TAB1, TFPI, TGFBR1, TGFBR2, TP53, TPR, TRADD, TSC1, TSC2, UBE2F, USP15, USP16, USP21, USP38, VEGFA, WEE1, XRCC3, ZMIZ1, ZMYND8, ZNF655]	TRUE
WP:1992	WikiPathways_09.11.2015	TarBasePathway	[-1]	[Group1, Group2]	1	5.5555553	0.1919855982696155	1.0	{Group1=0.056714486052509484, Group2=2.9863853183912796E-5}	{Group1=0.3402869163150569, Group2=3.2850238502304073E-4}	[IGF1]	[ERG, GJA1, HAND2, HCN2, HCN4, HDAC4, IGF1, KCNE1, KCNJ2, KCNQ1, LOC102723475, MIR1-1, MIR133A1, MIR133A2, MIR133B, PTBP2, SRF, TMSB4X]	FALSE
WP:2011	WikiPathways_09.11.2015	SREBF and miR33 in cholesterol and lipid homeostasis	[-1]	[Group2]	1	5.5555553	0.1919855982696155	1.0	{Group2=2.9863853183912796E-5}	{Group2=3.2850238502304073E-4}	[MTOR]	[ABCA1, FASN, HMGCR, HMGCS1, LDLR, MED15, MIR33A, MIR33B, MTOR, NR1H3, PPARA, PPARGC1A, PRKAA1, SCD, SIRT1, SIRT6, SREBF1, SREBF2]	FALSE
WP:2035	WikiPathways_09.11.2015	FSH signaling pathway	[-1]	[Group2]	2	7.4074073	0.03947803913674933	0.7895607827349865	{Group2=2.9863853183912796E-5}	{Group2=3.2850238502304073E-4}	[CREB1, MTOR]	[AKT1, APPL1, AREG, BDNF, CGA, CREB1, CYP19A1, EIF4EBP1, FOXO1, FSHB, FSHR, GRK6, HIST3H3, MAPK1, MAPK14, MAPK3, MTOR, PRKACA, PRKCA, RAF1, RHEB, RPS6, RPS6KB1, RPS6KB2, SGK1, SRC, TSC2]	FALSE
WP:2036	WikiPathways_09.11.2015	TWEAK Signaling Pathway	[-1]	[Group2]	2	4.7619047	0.08667909303650473	1.0	{Group2=2.9863853183912796E-5}	{Group2=3.2850238502304073E-4}	[BIRC2, NFKB2]	[AKT1, AKT2, BIRC2, BIRC3, CASP3, CASP7, CASP8, CCL2, CCL5, CHUK, CTNNB1, FADD, GSK3B, HDAC1, IKBKB, IL6, JUN, MAP3K14, MAP3K7, MAPK1, MAPK14, MAPK3, MAPK8, MAPK9, MMP9, NFKB1, NFKB2, NFKBIA, NFKBIB, RAC1, RAF1, RELA, RELB, RIPK1, TNF, TNFRSF12A, TNFSF12, TRAF1, TRAF2, TRAF3, TRAF5, TRIM63]	FALSE
WP:2203	WikiPathways_09.11.2015	TSLP Signaling Pathway	[-1]	[Group2]	2	4.255319	0.10491445045645867	1.0	{Group2=2.9863853183912796E-5}	{Group2=3.2850238502304073E-4}	[MTOR, NFKB2]	[AKT1, BTK, CCL11, CISH, CRLF2, CXCL8, EIF4EBP1, FES, FYN, GAB2, HCK, IL2RA, IL6, IL7R, JAK1, JAK2, LCK, LYN, MAP2K1, MAP2K2, MAPK1, MAPK14, MAPK3, MAPK8, MAPK9, MTOR, MYC, NFKB1, NFKB2, NFKBIA, PI4K2A, PIK3CA, PTPN11, RELA, RELB, RPS6, SRC, STAT1, STAT3, STAT4, STAT5A, STAT5B, STAT6, TEC, TNFSF4, TSLP, YES1]	FALSE
WP:2289	WikiPathways_09.11.2015	Drug Induction of Bile Acid Pathway	[-1]	[Group1]	1	5.882353	0.1823422103073768	1.0	{Group1=0.056714486052509484}	{Group1=0.3402869163150569}	[ABCB1]	[ABCB1, ABCB11, ABCC2, ABCC3, ABCC4, BAAT, CYP3A4, CYP7A1, NR1H4, NR1I2, NR1I3, SLC10A1, SLC51A, SLC51B, SLCO1B1, SULT2A1, VDR]	FALSE
WP:2332	WikiPathways_09.11.2015	Interleukin-11 Signaling Pathway	[-1]	[Group2]	2	4.5454545	0.09384971260086374	1.0	{Group2=2.9863853183912796E-5}	{Group2=3.2850238502304073E-4}	[BIRC5, CREB1]	[AKT1, ATF1, BCL2, BGLAP, BIRC5, CHUK, CREB1, FES, FYN, GRB2, HRAS, IBSP, ICAM1, IKBKB, IL11, IL11RA, IL6ST, ITGA2, JAK1, JAK2, MAP2K1, MAP2K2, MAPK1, MAPK3, PDPK1, PIAS1, PIAS3, PIK3R1, PIK3R2, PPP2R4, PTPN11, RAF1, RELA, RPS6, RPS6KA1, RPS6KB1, RUNX2, SOCS3, SRC, STAT1, STAT3, TGFB1, TYK2, YES1]	FALSE
WP:2369	WikiPathways_09.11.2015	Histone Modifications	[-1]	[Group5]	2	4.0816326	0.11248039079889402	1.0	{Group5=0.11248039079889402}	{Group5=0.5624019539944701}	[KMT2C, KMT2E]	[AEBP2, ASH1L, DOT1L, EED, EHMT1, EHMT2, EZH1, EZH2, H3F3A, H3F3B, HIST1H3D, HIST1H3J, HIST1H4C, HIST1H4H, HIST1H4J, HIST2H3A, HIST2H3C, HIST2H3D, HIST4H4, KMT2A, KMT2C, KMT2D, KMT2E, KMT5A, KMT5B, KMT5C, NSD1, PRDM2, SET, SETBP1, SETD1A, SETD1B, SETD2, SETD3, SETD4, SETD5, SETD6, SETD7, SETD9, SETDB1, SETDB2, SETMAR, SMYD1, SMYD2, SMYD3, SMYD4, SMYD5, SUV39H1, SUV39H2]	TRUE
WP:2446	WikiPathways_09.11.2015	Retinoblastoma (RB) in Cancer	[-1]	[Group11]	7	7.9545455	6.447650395972519E-5	0.002385630646509832	{Group11=1.2070874642210286E-5}	{Group11=1.4485049570652343E-4}	[CDC25A, DCK, PCNA, PRKDC, RRM2, TYMS, WEE1]	[ABL1, ANLN, BARD1, CCDC6, CCNA2, CCNB1, CCNB2, CCND1, CCND3, CCNE1, CCNE2, CDC25A, CDC25B, CDC45, CDC7, CDK1, CDK2, CDK4, CDK6, CDKN1A, CDKN1B, CDT1, CHEK1, DCK, DHFR, DNMT1, E2F1, E2F2, E2F3, FAF1, FANCG, H2AFZ, HDAC1, HLTF, HMGB1, HMGB2, KIF4A, MAPK13, MCM3, MCM4, MCM6, MCM7, MDM2, MIR21, MSH6, MYC, NPAT, ORC1, PCNA, PLK4, POLA1, POLD3, POLE, POLE2, PRIM1, PRKDC, PRMT2, RABIF, RAF1, RB1, RBBP4, RBBP7, RBP1, RFC3, RFC4, RFC5, RPA1, RPA2, RPA3, RRM1, RRM2, SAP30, SIN3A, SKP2, SMARCA2, SMC1A, SMC2, SMC3, STMN1, SUV39H1, TFDP1, TFDP2, TOP2A, TP53, TTK, TYMS, WEE1, ZNF655]	FALSE
WP:2453	WikiPathways_09.11.2015	TCA Cycle and PDHc	[-1]	[Group6]	1	6.25	0.17258577446938866	1.0	{Group6=0.17258577446938866}	{Group6=0.517757323408166}	[DLAT]	[ACLY, ACO1, CS, DLAT, DLD, DLST, FH, IDH1, IDH3A, MDH1, OGDH, PC, PCK1, PDHA1, SDHA, SUCLG2]	TRUE
WP:2516	WikiPathways_09.11.2015	ATM Signaling Pathway	[-1]	[Group11, Group2]	4	10.256411	0.0010385389502080946	0.035310324307075217	{Group11=1.2070874642210286E-5, Group2=2.9863853183912796E-5}	{Group11=1.4485049570652343E-4, Group2=3.2850238502304073E-4}	[BRCA1, CDC25A, CREB1, TLK1]	[ABL1, AP3B2, ATF2, ATM, BID, BRCA1, CASP2, CCNB1, CDC25A, CDC25C, CDK1, CDK2, CDKN1A, CHEK1, CHEK2, CRADD, CREB1, FANCD2, GADD45A, H2AFX, IKBKG, JUN, MAPK9, MDC1, MDM2, MDM4, MRE11A, NBN, NFKBIA, PIDD1, RAD50, RAD51, RAD9A, RIPK1, SMC1A, TLK1, TP53, TP53BP1, TP73]	FALSE
WP:2795	WikiPathways_09.11.2015	Cardiac Hypertrophic Response	[-1]	[Group1, Group2, Group7]	3	5.5555553	0.025009690433550197	0.5252034991045541	{Group1=0.056714486052509484, Group2=2.9863853183912796E-5, Group7=0.0055153943105859015}	{Group1=0.3402869163150569, Group2=3.2850238502304073E-4, Group7=0.049638548795273116}	[IGF1, MAP3K1, MTOR]	[AKT1, AKT2, CALM1, CAMK2D, CDK7, CDK9, CHUK, EGF, FGF2, FGFR2, GSK3B, GUCA1A, HDAC4, HDAC5, HDAC7, HDAC9, IGF1, IKBKB, IKBKE, IKBKG, MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K5, MAP2K6, MAP2K7, MAP3K1, MAP3K14, MAP3K7, MAP4K1, MAPK1, MAPK14, MAPK3, MAPK7, MAPK8, MEF2A, MTOR, NFATC2, NFKB1, NPPA, NRG1, PDPK1, PLA2G2A, PPP3CA, PRKCA, PRKD1, PRKG1, RAC1, RAF1, TGFB1, TGFBR1, TNF, TNFRSF1A]	TRUE
WP:2848	WikiPathways_09.11.2015	Differentiation Pathway	[-1]	[Group1]	2	4.1666665	0.10867938781575831	1.0	{Group1=0.056714486052509484}	{Group1=0.3402869163150569}	[CSF1R, IGF1]	[ALK, BMP4, CNTF, CSF1, CSF1R, CXCR1, DKK1, EGF, EPO, FGF1, FGF10, FGF2, FGF4, FGF8, FLT3LG, FST, GDF5, HGF, IGF1, IL11, IL3, IL6, IL6R, INHBA, INS, KIT, KITLG, LEFTY1, NODAL, NOG, NOTCH1, NT5E, NTF4, PDGFA, PDGFB, SHH, TF, TGFB1, TGFB3, TNFSF11, TPO, VEGFA, WNT1, WNT2, WNT2B, WNT3A, WNT5A, WNT7B]	FALSE
WP:2946	WikiPathways_09.11.2015	Imatinib Resistance in Chronic Myeloid Leukemia	[-1]	[Group1]	2	4.0816326	0.11248039079889402	1.0	{Group1=0.056714486052509484}	{Group1=0.3402869163150569}	[ABCB1, CSF1R]	[ABCB1, ABCG2, ABL1, ANXA2R, BBX, BCL11A, BCR, CASZ1, CCND3, CDK6, CDKN1B, CPEB4, CSF1R, EPO, FLT1, FOXO3, GAB1, GAB2, GADD45A, HMGB2, IGF2BP1, KIT, LYL1, LYN, MAP2K6, MAVS, MYC, NOL4L, NOP2, NSD1, PDGFRA, PDGFRB, PEX14, PIM1, PIM2, PRKACA, PTP4A2, PVT1, RAB36, RPS6KA1, SKP2, SLC4A10, SLC4A7, SLC50A1, SLC7A3, SPRED1, SPRED2, TRIM28, ZC3HAV1]	FALSE
